Clinical practice guidelines: management of severe bronchiolitis in infants under 12 months old admitted to a pediatric critical care unit

C Milési, F Baudin, P Durand, G Emeriaud… - Intensive Care …, 2023 - Springer
Purpose We present guidelines for the management of infants under 12 months of age with
severe bronchiolitis with the aim of creating a series of pragmatic recommendations for a …

Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years

W Na'amnih, E Kassem, S Tannous, V Kagan… - Epidemiology & …, 2022 - cambridge.org
The study aim was to examine the incidence and risk factors of respiratory syncytial virus
(RSV) bronchiolitis hospitalisations and disease severity among infants. We compared …

[HTML][HTML] Risk Factors for Poor Outcomes in Children Hospitalized With Virus-associated Acute Lower Respiratory Infections: A Systematic Review and Meta-analysis

D Trusinska, ST Zin, E Sandoval… - The Pediatric …, 2024 - journals.lww.com
Background: Acute lower respiratory infection (ALRI) caused by respiratory viruses is among
the most common causes of hospitalization and mortality in children. We aimed to identify …

Case–control study of exclusive breast feeding and severe bronchiolitis in the United States

RJ Geller, NR Inhofe, CC Crifase… - Paediatric and …, 2023 - Wiley Online Library
Background Bronchiolitis is a major cause of infant illness, with few known modifiable risk
factors. Breast feeding may reduce risk of severe bronchiolitis, but the association of …

[HTML][HTML] Severe respiratory syncytial virus disease

Y Peña-López, J Sabater-Riera, P Raj - Journal of Intensive Medicine, 2024 - Elsevier
The burden of respiratory syncytial virus (RSV) disease is widely recognized. Main risk
factors for severe disease, such as extreme ages, chronic cardiopulmonary conditions, and …

Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration

ER Packnett, IH Winer, A Oladapo… - Human Vaccines & …, 2023 - Taylor & Francis
Palivizumab has been shown to decrease RSV-related hospitalization (RSVH) risk and
reduce RSVH severity. American Academy of Pediatrics (AAP) guidance on administration …

Resurgence of human respiratory syncytial virus during COVID‐19 pandemic in Southern Brazil

GC Fröhlich, TS Gregianini, FG Pinheiro… - Journal of Medical …, 2024 - Wiley Online Library
Abstract Respiratory Syncytial Virus (RSV) is an important cause of respiratory infection in
humans. Severe cases are common in children≤ 2 years old, immunocompromised …

Inpatient burden of respiratory syncytial virus in children≤ 2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022

M Wick, A Poshtiban, R Kramer… - Influenza and Other …, 2023 - Wiley Online Library
Background Respiratory syncytial virus (RSV) causes respiratory tract disease in seasonal
waves, primarily in infants and young children. This study aims to quantify the number of …

[HTML][HTML] Changes in T-Cell Subsets and Serum IFN-γ, IL-17, and IgE Levels in Children with Respiratory Syncytial Virus Capillary Bronchitis and Their Clinical …

Y Zhang, J Luo, H Wu, H Wang, X Sun - Disease Markers, 2022 - hindawi.com
Objective. To investigate the changes in T-cell subsets and serum IFN-γ, IL-17, and IgE
levels in children with respiratory syncytial virus capillary bronchitis and their clinical …

[HTML][HTML] 呼吸道合胞病毒感染在唐氏综合征儿童中的研究进展

王蓉, 刘恩梅, 邓昱 - Advances in Clinical Medicine, 2023 - hanspub.org
呼吸道合胞病毒是引起5 岁以下儿童急性下呼吸道感染最常见的病原体之一,
几乎所有儿童在两岁前都会经历一次RSV 感染. 特殊健康状态儿童是严重RSV 感染的危险因素 …